1. Home
  2. GRBK vs TVTX Comparison

GRBK vs TVTX Comparison

Compare GRBK & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Brick Partners Inc.

GRBK

Green Brick Partners Inc.

HOLD

Current Price

$63.04

Market Cap

2.8B

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$27.90

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRBK
TVTX
Founded
N/A
N/A
Country
United States
United States
Employees
620
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.3B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
GRBK
TVTX
Price
$63.04
$27.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
14
Target Price
$71.00
$36.62
AVG Volume (30 Days)
178.1K
1.0M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.89
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.07
$44.62
Revenue Next Year
$10.33
$31.76
P/E Ratio
$10.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$50.57
$12.91
52 Week High
$80.97
$42.13

Technical Indicators

Market Signals
Indicator
GRBK
TVTX
Relative Strength Index (RSI) 35.58 48.52
Support Level $62.33 $26.72
Resistance Level $63.32 $31.47
Average True Range (ATR) 1.61 1.15
MACD -0.16 0.10
Stochastic Oscillator 31.79 61.66

Price Performance

Historical Comparison
GRBK
TVTX

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment, which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgages and title.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: